H.R.2951 - Patients First Act of 2011

To intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes. view all titles (2)

All Bill Titles

  • Official: To intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes. as introduced.
  • Short: Patients First Act of 2011 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 7
  • All-Time: 1,947
 
Introduced
 
House
Passes
 
Senate
Passes
 
President
Signs
 

 
09/15/11
 
 
 
 
 
 
 

Sponsor

Representative

J. Forbes

R-VA

View Co-Sponsors (30)

Official Summary

Patients First Act of 2011 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may r

Official Summary

Patients First Act of 2011 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve:
(1) the creation of a human embryo for research purposes;
(2) the destruction or discarding of, or risk of injury to, a living human embryo; or
(3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act. Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act:
(1) is clearly consistent with the standards established in this Act, if conducted using human cells; and
(2) is prioritized in terms of potential for near-term clinical benefit in human patients.Requires the Secretary to report on peer reviewed stem cell research proposals that were not funded.

...Read the Rest


Latest Letters to Congress

See All Letters (1)
 


Vote on This Bill

0% Users Support Bill

0 in favor / 2 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC

Top-Rated Comments